JP2017537928A5
(cg-RX-API-DMAC10.html )
2018-12-27
JP2017520128A5
(cg-RX-API-DMAC10.html )
2018-06-21
JP2016065085A5
(cg-RX-API-DMAC10.html )
2016-06-30
HRP20220075T1
(hr )
2022-04-15
Tekuća formulacija koja sadrži nikotin za aerosolnu primjenu
WO2015192127A3
(en )
2016-03-17
Formulated receptor polypeptides and related methods
EP3016653A4
(en )
2017-02-22
Pyrrolo-pyrrole carbamate and related organic compounds, pharmaceutical compositions, and medical uses thereof
JP2017137500A5
(cg-RX-API-DMAC10.html )
2017-10-12
JP2020528637A5
(cg-RX-API-DMAC10.html )
2021-08-05
JP2015186128A5
(cg-RX-API-DMAC10.html )
2017-04-06
PL3445321T3
(pl )
2025-10-20
Sposoby, kompozycje i zastosowania obejmujące wybrane aldehydy podstawione grupami hydroksylowymi
LT3402782T
(lt )
2020-10-12
8-amino-2-okso-1,3-diaza-spiro-[4.5]-dekano dariniai
JP2016540019A5
(cg-RX-API-DMAC10.html )
2018-01-18
EP3555127C0
(en )
2024-12-18
AGENTS, USES AND METHODS
EP3253864A4
(en )
2018-10-17
Uses of daldinia sp. or volatile organic compounds derived therefrom
EP3585351A4
(en )
2020-12-30
ECOPHILIC ANTIMICROBIAL FORMULATIONS DISRUPTING BIOFILMS, THEIR DEVELOPMENT AND THEIR USES
DK4023651T3
(da )
2023-11-20
Optisk aktivt pyranochromenylphenolderivat og farmaceutisk sammensætning, der omfatter samme
JP2018519528A5
(cg-RX-API-DMAC10.html )
2019-06-27
JP2017176931A5
(cg-RX-API-DMAC10.html )
2018-12-20
WO2018211324A8
(en )
2019-05-09
Prodrugs for the treatment of disease
JP2018150270A5
(cg-RX-API-DMAC10.html )
2019-12-26
JP2016045189A5
(cg-RX-API-DMAC10.html )
2018-05-31
JP2015043197A5
(cg-RX-API-DMAC10.html )
2015-04-16
IT201800007580A1
(it )
2020-01-27
Composti 1,3,8-triazaspiro e loro uso come medicamenti
EP3634507C0
(en )
2025-01-15
ORAL EXTENDED DRUG DELIVERY PLATFORMS
EA201891848A1
(ru )
2019-02-28
Фармацевтическая композиция для применения в лечении фиброза